Diploid Genomics launched as a JCVI spinout led by J. Craig Venter, backed by Healthier Capital, to commercialize AI‑driven genomics analytics for research and diagnostics. The company plans to combine long‑read sequencing (PacBio, Oxford Nanopore), imaging and clinical data with AI models and to build a CLIA sequencing center in San Diego. Diploid positions itself to offer discovery and clinical‑grade insights across complex diseases by marrying advanced sequencing with analytics. The launch signals renewed investor interest in vertically integrated genomics companies pairing sequencing infrastructure with AI platforms.